Russia ready to start COVID-19 vaccine production in Algeria

08 December 2020


Russia is ready to produce coronavirus vaccine in Algeria and discussed this possibility with local authorities, Russian Ambassador to Algeria Igor Belyaev told RIA Novosti.

"We discussed this moment (possibility of vaccine production - ed.) during our meetings with the Ministers of Health and Pharmaceutical Industry (of Algeria - ed.). Russia is ready to cooperate with Algeria for vaccine production at the local level, I mean the Russian Direct Investment Fund, which distributes the vaccine outside the country," Belyaev said.

"The Russian Direct Investment Fund offers various forms of cooperation, including direct acquisition, technology transfer, joint production and participation in the third phase of the trial. These are the forms of (cooperation - ed.), which we offered to the Algerian side," the Ambassador said.

In August, the Russian Ministry of Health registered the world's first vaccine for the prevention of COVID-19, developed by Gamaleya Research Center. It was named "Sputnik V". The vaccine was created on the studied and proven platform of human adenoviral vectors, important advantages of which are safety, efficiency and absence of long-term negative consequences.

The third phase of clinical trials has been approved and is currently underway in Belarus, UAE, Venezuela and several other countries. Applications for over 1.2 billion doses of Sputnik V vaccine have been received from more than 50 countries. The vaccine for delivery to foreign markets will be produced by international partners of the Russian Direct Investment Fund in India, Brazil, China, South Korea and other countries.



GSV "Russia - Islamic World"

Photo: Creative Commons